Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Plos One|May 20, 2016
Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal ResistanceLuis Manso, Silvana Mourón, Michael Tress, et al.
Breast Cancer Research and Treatment|December 25, 2014
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancerSara Tolaney, Howard Burris, Elaina Gartner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 8, 2024
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studiesAinhoa Madariaga, Rodrigo Sánchez-Bayona, Lawrence Kasherman, et al.
Breast Cancer Research and Treatment|July 14, 2011
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)Milvia Zambetti, Mauro Mansutti, Patricia Gomez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2020
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast CancerAleix Prat, Yi-Hsuan Tsai, Tomás Pascual, et al.
The Lancet. Oncology|April 23, 2013
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 studySandra M Swain, Sung-Bae Kim, Javier Cortés, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 29, 2025
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025)Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 16, 2023
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori, et al.
The New England Journal of Medicine|February 19, 2015
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancerSandra M Swain, José Baselga, Sung-Bae Kim, et al.
International Journal of Molecular Sciences|June 26, 2026
Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast CancerLola R Nogueira, Ana Maderuelo, Manuel Alva Bianchi, et al.
Pageof 13